1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of Cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Guidelines for cervical cancer screening. GOI WHO Collaboration program. 2004 - 2005.
3. Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006;354:2645–54.
4. Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000. Lancet Oncol. 20012:27–32.
5. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121:829-46.
6. Morice P, Uzan C, Gouy S, Versharaegen C, Haie-Meder C. Gynaecological cancers in pregnancy. Lancet. 2012;379:558-69.
7. Summary report on HPV and cervical cancer statistics in India 2007.WHO/ICO Information Centre on HPV and Cervical Cancer .Available from: http://www.who.int/hpvcentre. Last assessed on May 1, 2008.
8. Mattila ML, Rautava P, Sillanpaa M, Paunio P. Caries in five-year-old children and associations with family-related factors. Journal of Dental Research 2000;79(3):875-81.
9. Hofer TP, Katz SJ. Health behaviors among women in the United States and Ontario: The effect of use of preventive care. American Journal of Public Health. 1996;86(12):1755-9.
10. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstetrics & Gynecology. 2000;96(5):653-56.
11. Mays RM, Zimet GD, Winston Y . Human papillomavirus, genital warts, pap smears, and cervical cancer: Knowledge and beliefs of adolescent and adult women. Health Care for Women International 2000;21:361-74.
12. Vural E, Gonenc L, Aka N. Antenatal kontrollerde pap smear taramasıvesonu-cları. Türkiye Aile Hekimligi Dergisi. 2004;8:111-5.
13. Diallo MO, Ettiègne-Traoré V, Maran M, Kouadio J, Brattegaard K, Makke A et al. Sexually transmitted and human immunodeficiency virus infections in women attending an antenatal clinic in Abidjan, Cote d'Ivoire. Int J STD AIDS. 1997;8:636-8.
14. Ayres de Campos D, Nogueira A, Magalhães F, Bayer P, Monteiro J, Lameirão A et al. Inflammatory smears in cervicovaginal cytology: A finding meaning infection? Acta Med Port. 1997;10:637-41.
15. Lanouette JM, Puder KS, Berry SM, Bryant DR, Dombrowski MP. Is inflammation on Papanicolaou smear a risk factor for preterm delivery? Fetal DiagnTher. 1997;12:244-7.
16. Bedrossian UK, Fairfax MR, Ayers M. Pap smear follow-up of mucopurulent exudate as a prognostic indicator of a negative pregnancy outcome. Diagn Cytopathol. 1999;21:4-6
17. Ngaojaruwong N, Vuthiwong C, Punpuckdeekoon P, Thongsorn N. Prevalence of abnormal Papanicolaou smear in pregnant women at Phramongkutklao Hospital. Thai J Obstet Gynaecol. 2008;16:179-85.
18. Seda J, Avellanet Y, Roca FJ, Hernandez E, Umpierre SA, Romaguera J. Risk factors for abnormal cervical cytology in pregnant women attending the high-risk obstetrics clinic at the University Hospital in San Juan, Puerto Rico. P R Health Sci J. 2011;30:14-7.
19. Ozgun G, Aydogdu G. Distribution of cervical lesions & relation between age and parity rates in the Mardin province. Turk Patoloji Derg. 2013;29:46-50.
20. Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Deleré Y. Risk factors for cervical human papillomavirus infection & high grade intra epithelial lesion in women aged 20 to 31 years in Germany. Int J Gynaecol Cancer. 2013;23:519-26.
21. Daly SF, Doyle M, English J, Turner M, Clinch J, Prendiville W. Can the number of cigarettes smoked predict high-grade cervical intraepithelial neoplasia among women with mildly abnormal cervical smears? Am J Obstet Gynecol. 1998 Aug;179(2):399–402.
22. Ajah LO, Chigbu CO, Ozumba BC, Oguanuo TC, Ezeonu PO. Is there any association between hormonal contraceptives and cervical neoplasia in a poor Nigerian setting? Onco Targets Ther. 2015;9:1887-92.
DOI: https://dx.doi.org/10.18535/jmscr/v4i12.80
